heart cardiovascular Dr. Reddy's announced the launch of Nitroglycerin sublingual tablets, the generic version of Pfizer's Nitrostat. Dr. Reddy’s announced the launch of Nitroglycerin sublingual ...
Dr. Reddy’s Laboratories Ltd has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in ...
- trade names for nitroglycerin used as a coronary vasodilator in the treatment of angina pectoris ...
The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve months ending in March 2016 Dr Reddy’s Laboratories (DRL) has launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results